Apogee Therapeutics, Inc. · NASDAQ:APGE
Henderson Michael Thomas disposed of 920,941 Apogee Therapeutics, Inc. shares (Form 4)
Traded Sep 3, 2026 · Filed Sep 3, 2026
On Sep 3, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) disposed of 920,941 Apogee Therapeutics, Inc. shares, leaving 0 shares. Filed Sep 3, 2026 (Form 4).
- Disposed of
- 920,941 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | Disposition | 920,941 | 0 | Direct |
Source
Related
- Apogee Therapeutics, Inc.
- Henderson Michael Thomas
- Apogee Therapeutics, Inc. shareholders
- Form 4 · Henderson Michael Thomas · Jul 10, 2026
- Form 4 · Henderson Michael Thomas · Jun 24, 2026
- Form 4 · Henderson Michael Thomas · Jun 12, 2026
- Form 4 · Henderson Michael Thomas · May 15, 2026
- Form 4 · Henderson Michael Thomas · Apr 20, 2026
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026